Sublocade
Buprenorphine acts as a partial agonist, activating some opioid receptors in the brain to alleviate withdrawal symptoms and cravings.
Suboxone® is a brand-name prescription medicine consisting of naloxone and buprenorphine, both active ingredients. The Food and Drug Administration (FDA) approved its use in helping adults overcome opioid addictions in 2002.
Harvard University conducted a study in 2015 that concluded that Suboxone® tripled the likelihood of recovery and opioid abstinence for adults when paired with counseling or therapy versus seeking counseling alone.
By blocking the neuroreceptors, Suboxone® minimizes the impact of opioids on the brain, reducing cravings for the substance while assisting in long-term recovery.
Suboxone® helps patients successfully recover from opioid use disorder by mitigating withdrawal symptoms and reducing cravings. While using Suboxone®, patients can mitigate compulsive behaviors and gain control over their addiction.
By using Suboxone® alongside traditional counseling, patients with opioid use disorder can effectively stay in treatment longer without relapse, allowing for a more complete recovery.
Suboxone® is available in four different doses to support your unique needs: 2 mg buprenorphine/0.5 mg naloxone 4 mg buprenorphine/1 mg naloxone 8 mg buprenorphine/2 mg naloxone 12 mg buprenorphine/3 mg naloxone
Ready to take the first step toward recovery? Brightside uses telehealth to ensure everyone can access life-saving addiction treatment no matter where they are. Schedule your virtual visit today!
